66 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Mirati Therapeutics, Inc. MRTX gained 31.6 percent to close at $89.20 on Monday in sympathy with Amgen after the company presented the first clinical data evaluating a KRASG12C inhibitor, AMG 510, at ASCO 2019.
  • ARCA biopharma, Inc. ABIO shares jumped 27.1 percent to close at $7.36 on Monday.
  • Cypress Semiconductor Corporation CY climbed 23.9 percent to close at $22.07. Cypress Semiconductor confirmed it has agreed to be acquired by Infineon Technologies AG IFNNY for $23.85 per share in cash, translating to an enterprise value of 9 billion euros, or $10.05 billion.
  • Eyegate Pharmaceuticals Inc EYEG shares jumped 23 percent to close at $0.3100 after the company received FDA approval to initiate its photorefractive keratectomy pivotal study.
  • Spirit MTA REIT SMTA gained 19.8 percent to close at $8.42. Spirit MTA REIT agreed to sell a net lease portfolio to Hospitality Properties Trust for $2.4 billion in cash.
  • Genocea Biosciences, Inc. GNCA climbed 19.6 percent to close at $6.71 on Monday after the company presented results from its ongoing Phase 1/2a trial for GEN-009, the company's lead neoantigen vaccine candidate, at ASCO 2019.
  • E.I. du Pont de Nemours and Com DD gained 17.8 percent to close at $76.10.
  • Dyadic International, Inc. DYAI climbed 15.7 percent to close at $5.15.
  • Avenue Therapeutics, Inc. ATXI gained 15 percent to close at $5.98 after the company announced its second pivotal Phase 3 trial of IV tramadol met its primary and key secondary endpoints.
  • Atomera Incorporated ATOM climbed 14.7 percent to close at $4.84.
  • El Paso Electric Company EE rose 13.5 percent to close at $66.08 after the company agreed to be acquired by the Infrastructure Investments Fund for $68.25 per share in cash.
  • Centrus Energy Corp. LEU gained 13.4 percent to close at $3.4240.
  • Daqo New Energy Corp. DQ rose 13.3 percent to close at $43.07.
  • Eldorado Gold Corporation EGO gained 12.6 percent to close at $4.19.
  • Sellas Life Sciences Group Inc SLS rose 11.8 percent to close at $0.5625 after the company announced breast cancer data from its study of Nelipepimut-S plus Trastuzumab at ASCO 2019.
  • Odonate Therapeutics, Inc. ODT climbed 11.8 percent to close at $24.03.
  • Gold Fields Limited GFI surged 11.2 percent to close at $4.96.
  • Resonant Inc. RESN climbed 10.8 percent to close at $2.66.
  • Aquestive Therapeutics, Inc. AQST gained 10.5 percent to close at $4.1100.
  • Iovance Biotherapeutics, Inc. IOVA gained 10.3 percent to close at $18.04.
  • Tailored Brands, Inc. TLRD surged 9.9 percent to close at $5.78.
  • Seelos Therapeutics, Inc. SEEL gained 9.6 percent to close at $2.62.
  • HC2 Holdings, Inc. HCHC rose 9.5 percent to close at $2.53.
  • Nektar Therapeutics NKTRgained 8.8 percent to close at $34.06 in sympathy with Amgen after the company presented the first clinical data evaluating a KRASG12C inhibitor, AMG 510, at ASCO 2019.
  • Huami Corporation HMI rose 8.5 percent to close at $7.95 after reporting a first-quarter earnings beat.
  • Nektar Therapeutics NKTR shares rose 8.8 percent to close at $34.06 after presenting biomarker and clinical data from PIVOT-02 Phase 2 study of bempegaldesleukin with nivolumab at the ASCO Annual Meeting.
  • Compass Diversified Holdings LLC CODI gained 8 percent to close at $16.79.
  • Heat Biologics Inc HTBX shares gained 7.9 percent to close at $0.8847 after the company announced interim Phase 2 lung cancer data showing that its HS-110 demonstrated clinical activity in tumor patients.
  • Rexahn Pharmaceuticals, Inc. RNN climbed 7.7 percent to close at $5.31.
  • Outlook Therapeutics, Inc. OTLK rose 7.5 percent to close at $2.5800 after signing a manufacturing supply agreement with FUJIFILM Diosynth Biotechnologies as a part of commercialization strategy for ONS-5010.
  • Deciphera Pharmaceuticals, Inc. DCPH gained 7.2 percent to close at $24.46.


Losers

  • FTD Companies Inc FTD tumbled 75 percent to close at $0.1898 after the company filed voluntary Chapter 11 petitions to facilitate the completion of strategic initiatives. The company will also be delisted from the Nasdaq.
  • DelMar Pharmaceuticals Inc DMPI fell 49.8 percent to close at $2.05 after the company announced a $3.6 million registered direct offering.
  • Aduro BioTech, Inc. ADRO fell 40.3 percent to close at $1.94. Aduro Biotech and Novartis presented results from ongoing Phase 1b study of STING agonist ADU-S100 (MIW815) in combination with anti-PD-1 monoclonal antibody spartalizumab (PDR001) in patients with advanced solid tumors or lymphomas at the ASCO 2019.
  • Pintec Technology Holdings Limited PT dipped 26.2 percent to close at $5.68.
  • Mesa Laboratories, Inc. MLAB fell 25.7 percent to close at $185.45 following Q4 earnings.
  • ContraVir Pharmaceuticals, Inc. CTRV tumbled 25.3 percent to close at $5.60.
  • Support.com, Inc. SPRT dropped 22 percent to close at $1.74 in sympathy with Google and Amazon after the FTC and DOJ decided to put the two tech giants under antitrust oversight.
  • Eltek Ltd. ELTK dipped 21.1 percent to close at $5.75.
  • Soliton, Inc. SOLY shares tumbled 19.5 percent to close at $15.15.
  • Vical Incorporated VICL fell 19.1 percent to close at $0.9300 after the company announced an all-stock merger agreement with Brickell Biotech.
  • Five Prime Therapeutics, Inc. FPRX dropped 18.8 percent to close at $6.82 after Wells Fargo downgraded the company's stock from Outperform to Market Perform and lowered the price target from $35 to $10.
  • Cyclerion Therapeutics, Inc. CYCN shares declined 18.7 percent to close at $11.34.
  • TrueCar, Inc. TRUE fell 18.7 percent to close at $5.30 after the company reported the retirement of CEO Chip Perry.
  • Zynerba Pharmaceuticals, Inc. ZYNE shares declined 15.4 percent to close at $10.46.
  • Flexible Solutions International Inc. FSI dropped 14.2 percent to close at $2.9700.
  • Vuzix Corporation VUZI shares declined 12.5 percent to close at $1.82.
  • BioSig Technologies, Inc. BSGM dipped 11.8 percent to close at $6.71. BioSig Technologies received $4.6 million in warrant and option exercises in Q1 and Q2 2019.
  • ReWalk Robotics Ltd. RWLK fell 11.3 percent to close at $3.15.
  • RISE Education Cayman Ltd REDU tumbled 11.1 percent to close at $8.07.
  • Myovant Sciences Ltd. MYOV dipped 11.1 percent to close at $8.74.
  • Research Frontiers Incorporated REFR dropped 10.9 percent to close at $2.61.
  • Tocagen Inc. TOCA fell 10.6 percent to close at $4.55.
  • TuanChe Limited TC dropped 10.3 percent to close at $3.99. TuanChe entered into an agreement to acquire Longye International Limited.
  • Centene Corporation CNC fell 10.3 percent to close at $51.82 after Humana announced it would not propose to merge with Centene.
  • Paylocity Holding Corporation PCTY fell 10.3 percent to close at $89.87.
  • Natural Health Trends Corp. NHTC dropped 10.3 percent to close at $9.13.
  • Celldex Therapeutics, Inc. CLDX fell 10.2 percent to close at $2.7300 after presenting results from the CDX-3379 clinical program at the 2019 American Society of Clinical Oncology Annual Meeting in Chicago.
  • Kaixin Auto Holdings KXIN fell 10 percent to close at $2.16 after receiving notice of delisting for warrants.
  • Precipio, Inc. PRPO tumbled 9.2 percent to close at $4.9500.
  • NanoViricides Inc NNVC fell 9.1 percent to close at $0.2500 after the company received 'favorable' comments from the FDA regarding its pre-IND application for its lead drug candidate.
  • Conn's, Inc. CONN dropped 8.9 percent to close at $16.36.
  • Senmiao Technology Limited AIHS dropped 8.6 percent to close at $5.00.
  • KBS Fashion Group Limited KBSF dropped 8.1 percent to close at $2.8500 following Q1 results.
  • Quotient Limited QTNT dipped 7.8 percent to close at $8.92.
  • Alphabet Inc. GOOGL fell 6.1 percent to close at $1,038.74 after the Justice Department announced an antitrust investigation into Google.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralLosersMovers From MondayMovers From YesterdayTop GainersYesterday's Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...